Bausch Health Companies Inc.
Financials
Estimates*
USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Revenues | 8.0b | 8.4b | 8.1b | 8.8b | 9.5b | 9.8b | 10.1b |
% growth | (7 %) | 5 % | (4 %) | 8 % | 8 % | 3 % | 3 % |
EBITDA | 2.5b | 2.6b | 2.6b | 2.9b | 3.2b | 3.4b | 3.6b |
% EBITDA margin | 31 % | 31 % | 32 % | 33 % | 34 % | 34 % | 36 % |
Profit | (560m) | (948m) | (225m) | (592m) | 79.1m | 377m | 432m |
% profit margin | (7 %) | (11 %) | (3 %) | (7 %) | 1 % | 4 % | 4 % |
EV / revenue | 3.7x | 3.6x | 0.3x | 0.3x | 2.4x | 2.2x | 0.2x |
EV / EBITDA | 11.7x | 11.8x | 0.9x | 1.0x | 7.1x | 6.3x | 0.6x |
R&D budget | 452m | 465m | 529m | 604m | - | - | - |
R&D % of revenue | 6 % | 6 % | 7 % | 7 % | - | - | - |
Date | Investors | Amount | Round |
---|---|---|---|
N/A | - | ||
N/A | N/A | IPO | |
N/A | $200m | Post IPO Debt | |
* | N/A | $1.0b | Post IPO Debt |
Total Funding | - |
Recent News about Bausch Health Companies Inc.
EditBausch Health Companies Inc. is a global health care company dedicated to improving lives through the development, manufacturing, and marketing of a wide range of health care products. The company primarily focuses on gastroenterology, neurology, dermatology, and international pharmaceuticals. Bausch Health serves patients, health care providers, and other stakeholders by delivering durable and innovative health care solutions.
Operating in the global health care market, Bausch Health's business model involves extensive research and development to create new products, as well as the acquisition of existing brands to expand its portfolio. The company generates revenue through the sale of its health care products to hospitals, clinics, and pharmacies worldwide.
Bausch Health is committed to innovation and invests heavily in future growth to ensure it remains at the forefront of medical advancements. The company also offers educational grants to support the latest breakthroughs in research and effective communication with families.
Keywords: gastroenterology, neurology, dermatology, pharmaceuticals, health care, innovation, durable brands, global market, research and development, educational grants.